$AMN

AMN Healthcare (AMN) Swings To Profit While Two Segments Keep Sliding

AMN Healthcare (AMN) reported Q2 revenue of $673.2M, up 2% YoY, with net income of $21.2M. Travel nurse and allied staffing revenue grew 10% and 8% YoY, respectively. However, Physician and Leadership Solutions revenue fell 6% and Technology and Workforce Solutions revenue dropped 15% YoY. The company expects these declines to continue in Q3.

Original reporting
Published Sep 15, 2026, 7:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 7:11 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AMN Healthcare (AMN) Swings To Profit While Two Segments Keep Sliding — source image
Decision brief

The 30-second read

$AMNNeutralMed
01

Why it matters

Earnings beat may trigger short-covering, but guidance suggests continued challenges.

02

Market read

First earnings disclosure with new guidance; relevant for traders monitoring healthcare staffing stocks.

03

What to watch

Cash flow drag from returning disruption deposits and guidance of further segment declines.

Relevance 7/10Novelty 8/10Timing: post-earnings release Aug 6

Background

AMN Healthcare reported Q2 2026 results, highlighting profit and segment performance.

Company-level read

Ticker impact

$AMNNeutralHigh confidence
Context

Q2 earnings release shows profit and segment growth, with guidance indicating continued decline in two segments.

Expected impact

Potential short-term upside on profit beat, but downside risk from segment declines and high short interest.

Evidence & confidence

First report of earnings with new numbers and guidance; market will react to profit surprise versus ongoing segment weakness.

Market effects

Staffing sector may see rotation toward travel nurse services as growth driver.

U.S. healthcare staffing market sentiment affected.

Limited to U.S. staffing industry.

Counterpoint

Despite profit, declining segments and high short interest could pressure the stock.

Key entities

  • AMN Healthcare Services

    U.S.-listed staffing firm (NYSE:AMN).

Related articles

$AMNMed

AMN Healthcare Adds AI Interpreting as Prices Squeezed

AMN Healthcare reported Q2 2026 language services revenue of $69.6m, down 8% YoY due to pricing pressure. Overall revenue rose 2% to $673.2m, with net income at $21.2m. The company acquired Jaide Health for AI interpreting services and expects Q3 revenue of $640m-$655m.

$AMNMedAI 9/10

AMN Healthcare (AMN) Q2 2026 Earnings Call Transcript

AMN Healthcare reported Q2 2026 revenue of $673 million, up 2% year over year and 6% above the top end of guidance, with adjusted EPS of $0.77. Adjusted EBITDA was $73 million (10.9% margin) after $27 million in nonrecurring billing true-ups. Q3 revenue guidance is $640 million to $655 million. AMN also authorized share repurchases and acquired Jaide Health and ESSENTIAL.

$AMNMedAI 8/10

5 Revealing Analyst Questions From AMN Healthcare Services’s Q2 Earnings Call

AMN Healthcare Services reported Q2 revenue of $673.2 million, above analysts’ $628.2 million estimate, and adjusted EPS of $0.77 versus $0.19. Management attributed results to strong Nurse and Allied Solutions demand, including travel nurse and allied volumes, plus higher labor disruption revenue and improved search and international execution. Q3 revenue guidance midpoint was $647.5 million.

$AMNHighAI 9/10

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS

AMN Healthcare Services (NYSE: AMN) reported Q2 2026 revenue of $673 million, up 2% year over year, and adjusted EBITDA of $73 million. GAAP net income was $21 million, or $0.53/share, and adjusted EPS was $0.77. The company said results exceeded guidance, citing travel nurse and allied growth, 27% search revenue growth, and acquisitions expanding AI and leadership offerings. Q3 revenue is expected 1-3% higher.